Beth Rogozinski
CEO, OncousticsProduct and commercialization leadership across AI diagnostics, digital health and regulated medical technology.
Leadership
The experience behind the intelligence.
miRoncol’s leadership spans company building, medical oncology, molecular diagnostics, clinical validation, bioinformatics, peer-reviewed microRNA research and marketing strategy.
Executive and scientific leadership
Meet the people building miRoncol.
Each profile explains not only who the person is, but why their experience matters to the platform and its translation.
BIOINFORMATICS · PUBLIC MANAGEMENT · COMPANY STRATEGY
Victoria Xu
Co-Founder & Chief Executive Officer
An entrepreneur and investor with graduate training spanning bioinformatics and public management. Victoria leads miRoncol’s strategy, operations and path from scientific opportunity to preventive-health applications.
Read full profile
20+ YEARS · MEDICAL ONCOLOGY · CLINICAL RESEARCH
Christopher M. Gallagher, MD
Co-Founder & Chief Medical Officer
A practicing medical oncologist with more than 20 years in cancer care and clinical research. Chris guides miRoncol’s clinical strategy, scientific discipline and patient-centred application.
Read full profile
FORMER ROCHE (FMI) SCIENTIFIC DIRECTOR · DIAGNOSTICS
Gilles Erb, PhD
Medical & Scientific Director
Gilles brings more than 20 years in oncology diagnostics and clinical validation, including experience as Global Scientific Director for Integrated Molecular Medicine at Roche (FMI).
Read full profile
BIOINFORMATICS · MICRORNA MODELS · PEER-REVIEWED RESEARCH
Hai Hu, PhD
Co-Founder & Chief Scientific Officer
An award-winning bioinformatics scientist and the scientific architect behind miRoncol’s peer-reviewed blood-based microRNA models for multi-cancer early detection.
Read full profile
20+ YEARS IN MARKETING · CANCER RESEARCH · TWO EXITS
Stephen Lau
Vice President, Marketing
A marketing and technology executive with more than 20 years of experience, a background in cancer research and experience through two company exits. Stephen leads miRoncol’s brand, investor narrative and digital go-to-market strategy.
Read full profileScientific Advisory Board
External perspective. Scientific accountability.
Physicians, scientists and biotechnology leaders contribute perspective across diagnostics, oncology, neuroscience, commercialization and clinical translation.
Jiah Pearson-Leary, PhD
CEO, Spire BioAdvisoryTranslational neuroscience and biotechnology strategy from scientific insight to viable application.
Vinona Bhatia, MD, MPH
Principal, AtapirClinical, regulatory and investment perspective across oncology, AI-enabled monitoring and startup development.
Hallgeir Rui, MD, PhD
Professor, Thomas Jefferson UniversityPhysician-scientist expertise connecting molecular cancer biology with translational oncology.
Jerry Lee, PhD
Professor, University of Southern CaliforniaA systems view of engineering, physics and oncology applied to collaborative cancer early-detection research.
A record of progress
Meet the milestones behind the team.
The news archive connects leadership appointments, research publications, awards and partnerships to the company’s development over time.